Intravenous Immunoglobulin Market Size, Segments, Growth Prospects 2012 – 2022

Intravenous Immunoglobulin Industry Overview

The global intravenous immunoglobulin market size was estimated at USD 9.09 billion in 2016 and is anticipated to grow at a CAGR of 7.1% over the forecast period.

Growing geriatric population, rising prevalence of immunodeficiency diseases, increasing adoption of IVIG treatments, and rising use of off-label indications are the key drivers of the market. Rising number of patients with immunodeficiency disorders is the primary cause for the development of IVIG preparations.

Gather more insights about the market drivers, restrains and growth of the Global Intravenous Immunoglobulin Market

According to the W.H.O, currently, there are over 50 different Primary Immune Deficiency (PID’s) such as specific antibody deficiency, X-lined hypo-gamma-globulinemia, and others. PIDs include 176 different types of rare hereditary disorders. According to the U.S. National Library of Medicine and National Institute of Health, approximately 6 million patients are suffering from PID worldwide. Growing incidences of these diseases are expected to boost the demand for immunoglobulin therapies over the forecast period.

The demand for IVIG therapies for the treatment of acquired and primary immunodeficiency diseases is increasing as it is the most effective & the only available treatment option. Moreover, sedentary lifestyle habits, including consumption of saturated fats salt, & sugars, less physical activities, and high alcohol consumption have led to an increase in the prevalence of these diseases. Rising prevalence of lifestyle-associated disorders such as obesity & antibody deficiency disorders are the factors expected to drive the growth.

The global geriatric population base is on a rise. According to a report published by the United States Census Bureau, the number of people aged 65 and older in the U.S. was approximately 46.2 million in 2014 and is expected to reach over 98 million by 2060. Aging also weakens immune systems and consequently heightens a patient’s susceptibility towards acquiring infectious diseases. The global base of geriatric population is expected to grow over the next few years is expected to serve this industry as a high impact rendering driver.

Browse through Grand View Research’s Pharmaceuticals Industry Research Reports.

• Medical Foods Market: The global medical foods market size was valued at USD 21.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030.
• Huntington’s Disease Treatment Market: The global huntington’s disease treatment market size was valued at USD 362.0 million in 2021 and is expected to expand a compound annual growth rate (CAGR) of 19.6% from 2022 to 2030.

Intravenous Immunoglobulin Market Segmentation

Grand View Research has segmented the global intravenous immunoglobulin market report on the basis of application, route of administration, and region:

• Intravenous Immunoglobulin Market Application Outlook (Revenue, USD Million, 2012 – 2022)
  • Hypogammaglobulinemia
  • CIPD
  • Immunodeficiency diseases
  • Congenital AIDS
  • Chronic Lymphocytic Leukemia
  • Myasthenia Gravis
  • Multifocal motor neuropathy
  • ITP
  • Kawasaki disease
  • Guillain-Barre syndrome
  • Others
• Intravenous Immunoglobulin Market Route of Administration Outlook (Revenue, USD Million, 2012 – 2022)
  • Intravenous
  • Subcutaneous
• Intravenous Immunoglobulin Market Regional Outlook (Revenue, USD Million, 2012 – 2022)
  • • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa (MEA)

  Market Share Insights

• January 2015: Grifols SA’s purification plant received FDA approval for the production of intravenous immunoglobulin (IVIG) 10%, plasma protein marketed under brands Gamunex and Flebogamma, thereby expanding its product portfolio and gaining more market share.

Key Companies profiled:

Some prominent players in the global intravenous immunoglobulin market include:

• Biotest AG
• Baxter International Inc.
• Octapharma AG
• LFB Biotechnologies
• Grifols SA
• CSL Behring
• China Biologics Products Inc.
• Kedrion Biopharma
• BDI Pharma Inc.

Order a free sample PDF of the Intravenous Immunoglobulin Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.